Stay updated with breaking news from Marriott Larson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares were up 7.7% during trading on Tuesday . The stock traded as high as $7.30 and last traded at $7.28. Approximately 567,886 shares traded hands during trading, a decline of 82% from the average daily volume of 3,240,086 shares. The stock had previously closed at $6.76. […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the firm’s stock in a transaction on Thursday, September 28th. The shares were sold at an average price of $7.72, for a total value of $23,160.00. Following the completion of the sale, the chief operating officer now owns 418,782 […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $8.66, for a total value of $25,980.00. Following the sale, the chief operating officer now directly owns 418,782 […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $8.66, for a total transaction of $25,980.00. Following the completion of the sale, the chief operating officer now directly owns 418,782 […]
Platinum Investment Management Ltd. grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,770,451 shares of the company’s stock after buying an additional 60,112 shares during the period. Platinum Investment Management Ltd.’s […]